New Drugs and Clinical Trials Rules, 2019: The market trumps ethics and participant rights
Indian J Med Ethics
;
2019 APR; 4(2): 89-91
Artículo
| IMSEAR
| ID: sea-195184
ABSTRACT
The enactment of the New Drugs and Clinical Trials Rules, 2019 (hereafter New Rules), on March 19 by the Ministry of Health and Family Welfare (MoHFW), Government of India (1), is the use of power delegated to the political executive by sub-section (1) of section 12 and sub-section (1) of section 33 of the Drugs and Cosmetics Act, 1940. Has this power been used wisely? Whose interests do these rules represent?
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Revista:
Indian J Med Ethics
Asunto de la revista:
Ethics
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS